Massive changes—including breakthroughs in digital health, the emergence of novel therapies, the rise of personalized care, and value-based care—are transforming health care. BCG helps health care organizations take action now so they can compete and thrive over the long term.
At the start of 2020, the global health care industry was already facing transformational changes driven by shifting consumer behaviors, the rise of disruptive competitors, changing regulations, and new alliances and mergers. To thrive in the face of such change—and in the postpandemic world—health care leaders need to reimagine their strategies, value propositions, and organizational capabilities. Our health care consulting teams help clients do so by adopting agile ways of working, accelerating innovation, advancing digital transformation, evolving go-to-market strategies, and driving growth and portfolio strategy through M&A. Across virtually every engagement, we help clients optimize capabilities through data, digital, and advanced analytics.
Our health care industry consultants work with payers, providers, health systems, and services to maximize innovation, unlock new sources of revenue, and improve patient outcomes and the quality of care.
We are working with global health organizations to launch and scale innovative interventions, fight disease, and manage overall population health.
At BCG, we work across the health care value chain to help our clients navigate their most pressing challenges, including:
Our health care consulting experts do this through an unrelenting commitment to innovation, collaboration, and industry-leading expertise. At BCG, we aim to create positive change in the world—for our clients as well as for patients and society—by helping clients deliver medical breakthroughs, innovative cures, and transformative patient experiences.
Discover what’s top of mind for health care CEOs and executives as they continue to navigate the challenges of the pandemic and imagine possibilities for the future.
To advance from promise to value, biopharma companies need to articulate and execute a bold vision for analytics as a fully scaled, continuously applied internal capability.
Powerful trends are shaping a promising yet challenging decade for the industry.